Bala Venkatesh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bala Venkatesh has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Rinaldo Bellomo
Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia
5 shared publications - Jeremy Cohen
The George Institute for Global Health, Sydney, Australia
3 shared publications Benoj Varghese
The Board of the College of Intensive Care Medicine of Australia and New Zealand, Melbourne, VIC, Australia
2 shared publicationsCharlie Corke
The Board of the College of Intensive Care Medicine of Australia and New Zealand, Melbourne, VIC, Australia
2 shared publicationsDianne Stephens
The Board of the College of Intensive Care Medicine of Australia and New Zealand, Melbourne, VIC, Australia
2 shared publicationsFelicity Hawker
The Board of the College of Intensive Care Medicine of Australia and New Zealand, Melbourne, VIC, Australia
2 shared publications
Latest Publications
- Open Access
- 29 October 2018
- Published by Springer Nature in Critical Care
- Vol. 22 (1) , 1-9
Vitamin D deficiency and supplementation in critical illness—the known knowns and known unknowns
The burgeoning literature on vitamin D deficiency and supplementation over the past decade or so has generated a greater understanding of some areas but also an appreciation of the many areas of equipoise. This is particularly relevant in the field of critical care with the heterogeneous patient populations, the severity and duration of illness and the frequency of comorbid conditions. This review aims to summarise the current knowledge base of vitamin D deficiency within the context of critical illness—“the known knowns”—and also highlight the areas of recognised uncertainty—“the known unknowns”. It acknowledges the fact that there may well be other knowledge gaps of clinical relevance of which we are currently unaware—“the unknown unknowns”.
- 29 October 2018
- Published by Springer Nature in Critical Care
- Vol. 22 (1) , 1-9
Open AccessVitamin D deficiency and supplementation in critical illness—the known knowns and known unknowns
The burgeoning literature on vitamin D deficiency and supplementation over the past decade or so has generated a greater understanding of some areas but also an appreciation of the many areas of equipoise. This is particularly relevant in the field of critical care with the heterogeneous patient populations, the severity and duration of illness and the frequency of comorbid conditions. This review aims to summarise the current knowledge base of vitamin D deficiency within the context of critical illness—“the known knowns”—and also highlight the areas of recognised uncertainty—“the known unknowns”. It acknowledges the fact that there may well be other knowledge gaps of clinical relevance of which we are currently unaware—“the unknown unknowns”.
- Open Access
- 10 September 2018
- Published by Springer Nature in Critical Care
- Vol. 22 (1) , 211
Women in Intensive Care study: a preliminary assessment of international data on female representation in the ICU physician workforce, leadership and academic positions
Despite increasing female enrolment into medical schools, persistent gender gaps exist in the physician workforce. There are limited published data on female representation in the critical care medicine workforce. To obtain a global perspective, societies (n = 84; 79,834 members (40,363 physicians, 39,471 non-physicians)) registered with the World Federation of Societies of Intensive and Critical Care Medicine were surveyed. Longitudinal data on female trainee and specialist positions between 2006-2017 were obtained from Australia and New Zealand. Data regarding leadership and academic faculty representation were also collected from national training bodies and other organisations of critical care medicine. Of the 84 societies, 23 had a registered membership of greater than 500 members. Responses were received from 27 societies (n = 55,996), mainly high-income countries, covering 70.1% of the membership. Amongst the physician workforce, the gender distribution was available from six (22%) participating societies—mean proportion of females 37 ± 11% (range 26–50%). Longitudinal data from Australia and New Zealand between 2006 and 2017 demonstrate rising proportions of female trainees and specialists. Female trainee and specialist numbers increased from 26 to 37% and from 13 to 22% respectively. Globally, female representation in leadership positions was presidencies of critical care organisations (0–41%), representation on critical care medicine boards and councils (8–50%) and faculty representation at symposia (7–34%). Significant gaps in knowledge exist: data from low and middle-income countries, the age distribution and the time taken to enter and complete training. Despite limited information globally, available data suggest that females are under-represented in training programmes, specialist positions, academic faculty and leadership roles in intensive care. There are significant gaps in data on female participation in the critical care workforce. Further data from intensive care organisations worldwide are required to understand the demographics, challenges and barriers to their professional progress.
- 10 September 2018
- Published by Springer Nature in Critical Care
- Vol. 22 (1) , 211
Open AccessWomen in Intensive Care study: a preliminary assessment of international data on female representation in the ICU physician workforce, leadership and academic positions
Despite increasing female enrolment into medical schools, persistent gender gaps exist in the physician workforce. There are limited published data on female representation in the critical care medicine workforce. To obtain a global perspective, societies (n = 84; 79,834 members (40,363 physicians, 39,471 non-physicians)) registered with the World Federation of Societies of Intensive and Critical Care Medicine were surveyed. Longitudinal data on female trainee and specialist positions between 2006-2017 were obtained from Australia and New Zealand. Data regarding leadership and academic faculty representation were also collected from national training bodies and other organisations of critical care medicine. Of the 84 societies, 23 had a registered membership of greater than 500 members. Responses were received from 27 societies (n = 55,996), mainly high-income countries, covering 70.1% of the membership. Amongst the physician workforce, the gender distribution was available from six (22%) participating societies—mean proportion of females 37 ± 11% (range 26–50%). Longitudinal data from Australia and New Zealand between 2006 and 2017 demonstrate rising proportions of female trainees and specialists. Female trainee and specialist numbers increased from 26 to 37% and from 13 to 22% respectively. Globally, female representation in leadership positions was presidencies of critical care organisations (0–41%), representation on critical care medicine boards and councils (8–50%) and faculty representation at symposia (7–34%). Significant gaps in knowledge exist: data from low and middle-income countries, the age distribution and the time taken to enter and complete training. Despite limited information globally, available data suggest that females are under-represented in training programmes, specialist positions, academic faculty and leadership roles in intensive care. There are significant gaps in data on female participation in the critical care workforce. Further data from intensive care organisations worldwide are required to understand the demographics, challenges and barriers to their professional progress.
- Open Access
- 1 June 2017
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 19 (2) , 183-191.e8
Statistical analysis plan for the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) trial
- 1 June 2017
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 19 (2) , 183-191.e8
Open AccessStatistical analysis plan for the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) trial
- Open Access
- 1 December 2016
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 18 (4) , 228-e12
Findings of the bullying, discrimination and sexual harassment survey: response of the College of Intensive Care Medicine
- 1 December 2016
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 18 (4) , 228-e12
Open AccessFindings of the bullying, discrimination and sexual harassment survey: response of the College of Intensive Care Medicine
- Open Access
- 1 December 2016
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 18 (4) , 230-234
Prevalence of bullying, discrimination and sexual harassment among trainees and Fellows of the College of Intensive Care Medicine of Australia and New Zealand
- 1 December 2016
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 18 (4) , 230-234
Open AccessPrevalence of bullying, discrimination and sexual harassment among trainees and Fellows of the College of Intensive Care Medicine of Australia and New Zealand
- 24 November 2016
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 375 (21) , 2105-2106
Publication of Secondary Analyses from Randomized Trials in Critical Care
The recent proposal by the International Committee of Medical Journal Editors (ICMJE) requiring authors to make deidentified individual-patient data publicly available within months of publication of a clinical trial has generated much debate.1-3 The debate has focused on opportunity costs to the scientific community and the appropriate time frame for the primary investigators to conduct and report secondary analyses. There are scarce published data on the publication rates and factors influencing these rates and the time taken to publish secondary analyses from clinical trials.
- 24 November 2016
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 375 (21) , 2105-2106
Publication of Secondary Analyses from Randomized Trials in Critical Care
The recent proposal by the International Committee of Medical Journal Editors (ICMJE) requiring authors to make deidentified individual-patient data publicly available within months of publication of a clinical trial has generated much debate.1-3 The debate has focused on opportunity costs to the scientific community and the appropriate time frame for the primary investigators to conduct and report secondary analyses. There are scarce published data on the publication rates and factors influencing these rates and the time taken to publish secondary analyses from clinical trials.
- 25 March 2016
- Published by Springer Nature
- p. 169-183
Adipokines in Critical Illness
- 1 January 2016
- Published by Springer Nature
- p. 507-515
Adrenal Insufficiency
- Open Access
- 15 December 2015
- Published by Springer Nature in Critical Care
- Vol. 19 (1) , 1-12
Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand
Background: Over the last two decades, there have been several improvements in the management of diabetes. Whether this has impacted on the epidemiology and outcome of diabetic ketoacidosis (DKA) requiring intensive care unit (ICU) admission is unknown. Method: This was a retrospective study of 8533 patients with the diagnosis of DKA admitted to 171 ICUs in Australia and New Zealand between 2000–2013 with separate independent analysis of those on established insulin (Group I) or not on insulin (Group NI) at the time of hospitalisation. Results: Of the 8553 patients, 2344 (27 %) were identified as NI. The incidence of ICU admission with DKA progressively increased fivefold from 0.97/100,000 (95 % CI 0.84–1.10) in 2000 to 5.3/100,000 (95 % CI 4.98–5.53) in 2013 (P < 0.0001), with the proportions between I and NI remaining stable. Rising incidences were observed mainly in rural and metropolitan hospitals (P < 0.01). In the first 24 hours in the ICU, mean worst pH increased over the study period from 7.20 ± 0.02 to 7.24 ± 0.01 (P < 0.0001), and mean lowest plasma bicarbonate from 12.1 ± 6.6 to 13.8 ± 6.6 mmol/L (P < 0.0001). In contrast, mean highest plasma glucose decreased from 26.3 ± 14 to 23.2 ± 13.1 mmol/L (P < 0.0001). Hospital mortality was significantly greater in NI as compared to I (2.4 % vs 1.1 %, P > 0.0001). Elevated plasma urea in the first 24 hours (≥25 mmol/L, adjusted odds ratio 20.6 (6.54–65.7), P < 0.0001) was the strongest individual predictor of mortality. Conclusions: The incidence of ICU admission of patients with DKA in Australia and New Zealand has increased fivefold over the last decade, with a significant proportion of patients not on insulin at presentation. Overall physiological status in the first 24 hours of ICU admission has progressively improved and mortality rates have remained stable. However, DKA patients not on established insulin therapy at presentation had significantly worse outcomes. This notion has epidemiologic, diagnostic and management implications.
- 15 December 2015
- Published by Springer Nature in Critical Care
- Vol. 19 (1) , 1-12
Open AccessIncidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand
Background: Over the last two decades, there have been several improvements in the management of diabetes. Whether this has impacted on the epidemiology and outcome of diabetic ketoacidosis (DKA) requiring intensive care unit (ICU) admission is unknown. Method: This was a retrospective study of 8533 patients with the diagnosis of DKA admitted to 171 ICUs in Australia and New Zealand between 2000–2013 with separate independent analysis of those on established insulin (Group I) or not on insulin (Group NI) at the time of hospitalisation. Results: Of the 8553 patients, 2344 (27 %) were identified as NI. The incidence of ICU admission with DKA progressively increased fivefold from 0.97/100,000 (95 % CI 0.84–1.10) in 2000 to 5.3/100,000 (95 % CI 4.98–5.53) in 2013 (P < 0.0001), with the proportions between I and NI remaining stable. Rising incidences were observed mainly in rural and metropolitan hospitals (P < 0.01). In the first 24 hours in the ICU, mean worst pH increased over the study period from 7.20 ± 0.02 to 7.24 ± 0.01 (P < 0.0001), and mean lowest plasma bicarbonate from 12.1 ± 6.6 to 13.8 ± 6.6 mmol/L (P < 0.0001). In contrast, mean highest plasma glucose decreased from 26.3 ± 14 to 23.2 ± 13.1 mmol/L (P < 0.0001). Hospital mortality was significantly greater in NI as compared to I (2.4 % vs 1.1 %, P > 0.0001). Elevated plasma urea in the first 24 hours (≥25 mmol/L, adjusted odds ratio 20.6 (6.54–65.7), P < 0.0001) was the strongest individual predictor of mortality. Conclusions: The incidence of ICU admission of patients with DKA in Australia and New Zealand has increased fivefold over the last decade, with a significant proportion of patients not on insulin at presentation. Overall physiological status in the first 24 hours of ICU admission has progressively improved and mortality rates have remained stable. However, DKA patients not on established insulin therapy at presentation had significantly worse outcomes. This notion has epidemiologic, diagnostic and management implications.
- Open Access
- 1 December 2015
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 17 (4) , 280-282
Diabetic ketoacidosis precipitated by therapy with antidiabetic agents SGLT2 inhibitors: two cases
- 1 December 2015
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 17 (4) , 280-282
Open AccessDiabetic ketoacidosis precipitated by therapy with antidiabetic agents SGLT2 inhibitors: two cases